Higher ADK levels track stronger triciribine effects in leukemia cells, pointing to a potential biomarker

A Karolinska Institutet study shows that leukemia cells with higher levels of the enzyme ADK are more sensitive to triciribine, because ADK converts triciribine into its active form inside the cell.